WPI 526 (Mononessa ethinyl estradiol 0.035 mg / norgestimate 0.25 mg)

Generic Name: ethinyl estradiol/norgestimate

Pill imprint WPI 526 has been identified as Mononessa ethinyl estradiol 0.035 mg / norgestimate 0.25 mg.

Mononessa is used in the treatment of birth control; ovarian cysts; abnormal uterine bleeding; endometriosis; gonadotropin inhibition and belongs to the drug class contraceptives. Not for use in pregnancy. Mononessa ethinyl estradiol 0.035 mg / norgestimate 0.25 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for WPI 526 (Mononessa ethinyl estradiol 0.035 mg / norgestimate 0.25 mg)

Mononessa ethinyl estradiol 0.035 mg / norgestimate 0.25 mg WPI 526
Mononessa
Generic Name:
ethinyl estradiol/norgestimate
Imprint:
WPI
526
Strength:
ethinyl estradiol 0.035 mg / norgestimate 0.25 mg
Color:
Blue
Shape:
Round
Availability:
Prescription only
Drug Class:
Contraceptives
Pregnancy Category:
X - Not for use in pregnancy
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
52544-0247
Inactive Ingredients:
FD&C Blue No. 2
aluminum oxide
ferric oxide red
carnauba wax
hypromelloses
croscarmellose sodium
lactose
magnesium stearate
polyethylene glycol
corn starch
microcrystalline cellulose
magnesium silicate
titanium dioxide
polysorbate 80

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web5)